Clinical trial
Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis
NCT03781310 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2018
- Completion date
- December 31, 2019
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis, tocilizumab